These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16621858)

  • 21. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
    Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
    Lucas AH; Azmi FH; Mink CM; Granoff DM
    J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines.
    West CE; Gothefors L; Granström M; Käyhty H; Hammarström ML; Hernell O
    Pediatr Allergy Immunol; 2008 Feb; 19(1):53-60. PubMed ID: 18086218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.
    Wong SL; Soosai P; Teoh YL; Han HH; Lefevre I; Bock HL
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):474-83. PubMed ID: 18564687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.
    Tejedor JC; Moro M; Merino JM; Gómez-Campderá JA; García-del-Rio M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Ruiz-Contreras J; Martin-Ancel A; Roca J; Boceta R; García-Corbeira P; Maechler G; Boutriau D;
    Pediatr Infect Dis J; 2008 Jul; 27(7):579-88. PubMed ID: 18536619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines.
    Denoël PA; Goldblatt D; de Vleeschauwer I; Jacquet JM; Pichichero ME; Poolman JT
    Clin Vaccine Immunol; 2007 Oct; 14(10):1362-9. PubMed ID: 17699836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins.
    Lee YC; Newport MJ; Goetghebuer T; Siegrist CA; Weiss HA; Pollard AJ; Marchant A;
    Vaccine; 2006 Jun; 24(25):5335-40. PubMed ID: 16701924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
    Hesseling AC; Blakney AK; Jones CE; Esser MM; de Beer C; Kuhn L; Cotton MF; Jaspan HB
    Vaccine; 2016 Jul; 34(32):3702-9. PubMed ID: 27055019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.
    Ritz N; Mui M; Balloch A; Curtis N
    Vaccine; 2013 Jun; 31(30):3098-103. PubMed ID: 23583897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dietary nucleotide supplementation on growth and immune function in term infants: a randomized controlled trial.
    Hawkes JS; Gibson RA; Roberton D; Makrides M
    Eur J Clin Nutr; 2006 Feb; 60(2):254-64. PubMed ID: 16234834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study.
    Baqui AH; El Arifeen S; Saha SK; Persson L; Zaman K; Gessner BD; Moulton LH; Black RE; Santosham M
    Pediatr Infect Dis J; 2007 Jul; 26(7):565-71. PubMed ID: 17596795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely.
    Omeñaca F; Garcia-Sicilia J; Boceta R; Sistiaga-Hernando A; García-Corbeira P
    Pediatr Infect Dis J; 2007 Sep; 26(9):824-9. PubMed ID: 17721379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses to immunisation with Hib conjugate vaccine in Australian breastfed and formula-fed infants.
    Hawkes JS; Makrides M; Roberton DM; Gibson RA
    J Paediatr Child Health; 2007 Sep; 43(9):597-600. PubMed ID: 17688643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States.
    Dennehy PH; Bertrand HR; Silas PE; Damaso S; Friedland LR; Abu-Elyazeed R
    Pediatrics; 2008 Nov; 122(5):e1062-6. PubMed ID: 18977955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants.
    Bavdekar SB; Maiya PP; Subba Rao SD; Datta SK; Bock HL
    Indian Pediatr; 2007 Jul; 44(7):505-10. PubMed ID: 17684303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
    Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
    Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
    Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.